找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-based Anticancer Materia Medica; William C.S. Cho Book 2011 Springer Science+Business Media B.V. 2011 Anticancer drug.Complementa

[復(fù)制鏈接]
樓主: Monsoon
51#
發(fā)表于 2025-3-30 08:33:05 | 只看該作者
52#
發(fā)表于 2025-3-30 15:51:52 | 只看該作者
53#
發(fā)表于 2025-3-30 20:07:41 | 只看該作者
An Evidence-based Perspective of , (Lucid Ganoderma) for Cancer Patients,anticancer effects of lucid ganoderma in cell and animal models could be the strong references for the clinical trials. The components with anticancer potential in lucid ganoderma include triterpenoids, steroids, polysaccharides, fatty acids, and novel proteins such as LZ-8. On the basis of . and .
54#
發(fā)表于 2025-3-30 21:47:58 | 只看該作者
An Evidence-based Perspective of , (Multicolored Polypore Mushroom) for Cancer Patients, possible applications for supportive cancer care and therapy. Modulation of innate and adaptive immunity, hematopoietic activity, and direct cytotoxic effects are reviewed with detailed analysis of molecular targets and signaling pathways affected by mushroom components and/or secondary metabolites
55#
發(fā)表于 2025-3-31 01:45:50 | 只看該作者
An Evidence-based Perspective of , (Shiitake Mushroom) for Cancer Patients,tive strategy to control and ultimately overcome cancer. Here, we will summarize the antitumor activity and immunomodulating action of biologically active polysaccharides, mostly β-glucans, from shiitake mushroom fruit bodies and/or cultured mycelium based on experimental and clinical findings. The
56#
發(fā)表于 2025-3-31 06:44:19 | 只看該作者
57#
發(fā)表于 2025-3-31 09:32:19 | 只看該作者
58#
發(fā)表于 2025-3-31 16:52:25 | 只看該作者
59#
發(fā)表于 2025-3-31 20:33:34 | 只看該作者
An Evidence-based Perspective of Herbal Remedies for Cancer Patients,efore acceptance of herbal remedies into wide scale clinical use can be achieved, two critical issues need to be addressed; these include a clearer understanding of their precise mechanism of action, along with supporting empirical clinical data on efficacy. In this chapter, firstly, we describe the
60#
發(fā)表于 2025-4-1 01:31:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 15:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
刚察县| 沙田区| 石渠县| 博白县| 莆田市| 沁阳市| 永平县| 无棣县| 交城县| 漳浦县| 岳普湖县| 海宁市| 寿宁县| 连山| 仙游县| 徐闻县| 叶城县| 方城县| 宁南县| 台东市| 泸水县| 沙河市| 广丰县| 韶山市| 延边| 浮山县| 保山市| 同心县| 衡水市| 安庆市| 峨眉山市| 东城区| 阿拉善右旗| 崇文区| 华坪县| 河曲县| 公主岭市| 肇庆市| 星子县| 乐都县| 通城县|